Fuva Brain Limited
Fuva Brain Limited Fundamental Analysis
Fuva Brain Limited (3927.T) shows moderate financial fundamentals with a PE ratio of 15.17, profit margin of 7.81%, and ROE of 18.56%. The company generates $5.4B in annual revenue with strong year-over-year growth of 42.19%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 70.1/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze 3927.T's fundamental strength across five key dimensions:
Efficiency Score
Weak3927.T struggles to generate sufficient returns from assets.
Valuation Score
Moderate3927.T shows balanced valuation metrics.
Growth Score
Moderate3927.T shows steady but slowing expansion.
Financial Health Score
Excellent3927.T maintains a strong and stable balance sheet.
Profitability Score
Weak3927.T struggles to sustain strong margins.
Key Financial Metrics
Is 3927.T Expensive or Cheap?
P/E Ratio
3927.T trades at 15.17 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 3927.T's PEG of 4.04 indicates potential overvaluation.
Price to Book
The market values Fuva Brain Limited at 2.89 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 21.28 times EBITDA. This signals the market has high growth expectations.
How Well Does 3927.T Make Money?
Net Profit Margin
For every $100 in sales, Fuva Brain Limited keeps $7.81 as profit after all expenses.
Operating Margin
Core operations generate 5.13 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $18.56 in profit for every $100 of shareholder equity.
ROA
Fuva Brain Limited generates $5.71 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Fuva Brain Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Fuva Brain Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
3927.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
15.17
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
4.04
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.89
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.18
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.18
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.50
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.19
vs 25 benchmark
ROA
Return on assets percentage
0.06
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How 3927.T Stacks Against Its Sector Peers
| Metric | 3927.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 15.17 | 33.61 | Better (Cheaper) |
| ROE | 18.56% | 1020.00% | Weak |
| Net Margin | 7.81% | -56528.00% (disorted) | Weak |
| Debt/Equity | 0.18 | 0.45 | Strong (Low Leverage) |
| Current Ratio | 1.50 | 5.65 | Neutral |
| ROA | 5.71% | -291484.00% (disorted) | Weak |
3927.T outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Fuva Brain Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
233.55%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
227.50%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
559.95%
Industry Style: Growth, Innovation, High Beta
High Growth